Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper

Super-backed company develops COVID treatment

A biotech company backed by AustralianSuper, HESTA, Hostplus and Statewide Super has developed a new preventative treatment shown to reduce COVID-19 levels by up to 96%.

Upgrade your subscription to access this article

And gain access to:
  • All archived news content
  • Access to the Financial Standard app
  • Home page news customisation
  • Financial Standard 's fortnightly newspaper
  • 25% discount on tickets to networking events
And more
Already A Subscriber?

Read more: Ena RespiratoryHESTAHostplusStatewide SuperBrandon CapitalFinancial StandardAustralianSuperChristophe DemaisonChris WilliamsMedical Research Commercialisation FundMH CarnegieSam SiciliaSonya Sawtell-Rickson